enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial

Go back to enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
(NASDAQ: NVNO) Delayed: 6.87 +0.14 (2.08%)
Previous Close $6.73    52 Week High $ 
Open $6.78    52 Week Low $ 
Day High $7.45    P/E N/A 
Day Low $6.78    EPS $ 
Volume 57,414